AddLife AB 주요 수익원은 MedTech이며, 최신 수익 발표에서 수익은 6,042,000,000입니다. 지역별로는 Other Countries이 AddLife AB의 주요 시장이며, 수익은 2,914,000,000입니다.
AddLife AB은 수익성이 있나요?
예, 최신 재무제표에 따르면 AddLife AB의 순이익은 $560입니다.
AddLife AB에 부채가 있나요?
예, AddLife AB의 부채는 7,268입니다.
AddLife AB의 발행 주식은 몇 주인가요?
AddLife AB의 총 발행 주식은 121.86주입니다.
주요 통계
이전 종가
--
시가
--
일일 범위
-
52주 범위
-
거래량
--
평균 거래량
--
배당수익률
--
EPS(TTM)
--
시가총액
--
ADDLY란 무엇인가요?
AddLife AB engages in the ownership and acquisition of firms in niche segments under the healthcare sector. The company is headquartered in Stockholm, Stockholm and currently employs 2,295 full-time employees. The company went IPO on 2015-03-16. The firm markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The firm operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The firm operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.